ABOUT THE PRODUCT
A Target-Site Blocker (TSB) targeting SIRT6, aimed at promoting vascular rejuvenation and addressing vascular aging.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Cardivia Labs Inc
CXCR4-TSB
Biotechnology
N/A
Cardivia Labs Inc
United States (US)